Bitwise's CEO announced that the minimum transaction amount for in-kind Bitcoin ETF trades has been reduced drastically from $50 million to $1 million over the past year. This $49 million decrease aims to broaden participation and make it easier for more investors to engage in Bitcoin ETF transactions. The CEO expressed gratitude to the team and partners for their efforts in expanding access. This change could encourage wider adoption and liquidity in Bitcoin ETFs going forward.
Bitwise CEO's announcement on Bitcoin ETF minimum transaction reduction provides context for crypto markets. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 14, 2026 01:41 WIB: 22 of 50 major cryptocurrencies rose, 27 fell. Bitcoin (BTC) traded at Rp1.254.154.978 with a 1-day change of -4.16%, typical hold time 113 days, and Pluang order activity showing 33% Sell / 67% Buy. Synthetix (SNX) rose 3.88% to Rp2.996 with 100% Sell orders, and Ethereum (ETH) fell 3.79% to Rp35.320.626 with 46% Sell / 54% Buy activity.
Susan R. Burns, Ph.D., President of the University of Mount Saint Vincent, has been awarded the 2027 Courageous Leadership Award for her visionary and bold leadership. Since 2021, she has led the university through significant transformation, includi...
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
Oppenheimer downgraded Enovix from Outperform to Perform as the company expands production in South Korea and shifts focus to drone and smart-eyewear customers. Enovix reported a 38% revenue increase to $11 million in Q3 but saw its adjusted loss wid...
